Abstract
Protection of mice against graft-versus-host disease (GVHD) can be accomplished by incubating donor marrow with anti-T-cell antisera or with an anti-Thy-1 monoclonal antibody. Incubation of donor marrow with a single anti-T-cell monoclonal antibody, however, does not prevent GVHD in humans. Therefore, we carried out a clinical trial to determine the effect of treatment of donor marrow with a combination of eight anti-T-cell antibodies in the absence of complement. The nine patients were genotypically HLA identical with their donors and received methotrexate postgrafting. Prompt engraftment occurred in eight patients. Of six patients surviving at least 40 days with sustained engraftment, three had severe (grade III or IV) GVHD. Thus, there is no evidence that treatment of donor marrow with murine anti-T-cell monoclonal antibodies as described here can prevent GVHD.
Similar content being viewed by others
References
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone marrow transplantation. N Engl J Med 292:832–843; 895–902, 1975
Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J, Doney K, Hansen JA, Mason M, Sanders JE, Singer J, Sullivan KM, Witherspoon RP, Thomas ED: Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. N Engl J Med 308:302–307, 1983
Yunis EJ, Good RA, Smith J, Stutman O: Protection of lethally irradiated mice by spleen cells from neonatally thymectomized mice. Proc Natl Acad Sci USA 71:2544–2548, 1974
Tulunay O, Good RA, Yunis EJ: Protection of lethally irradiated mice with allogeneic fatal liver cells: Influence of irradiation dose on immunologic reconstitution. Proc Natl Acad Sci (USA) 72:4100–4104, 1974
Rodt H, Thierfelder S, Eulitz M: Anti-lymphocytic antibodies and marrow transplantation. III. Effect of heterologous anti-brain antibodies on acute secondary disease in mice. Eur J Immunol 4:25–29, 1974
Rodt H, Kolb HJ, Netzel G, Hoffmann-Fezer G, Scholz S, Haas RJ, Bender-Gotze C, Wundisch F, Reider I, Wilms K, Thierfelder S: Prevention and treatment of GVHD by antithymocyte globulin.In Biology of Bone Marrow Transplantation, RP Gale (ed). New York, Academic Press, 1980, pp 221–245
Prentice HG, Janossy G, Skeggs D, Blacklock HA, Bradstock KF, Goldstein G, Hoffbrand AV: Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet 1:700–703, 1982
Filipovich AH, McGlave P, Ramsay NKC, Goldstein G, Warkentin PI, Kersey JH: Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-vs.-host disease in allogeneic histocompatible bone marrow transplantation. Lancet 1:1266–1269, 1982
Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL: Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 301:597–599, 1979
Ey PL, Prowse SJ, Jenkin CR: Isolation of pure IgG1, IgG2a and IgG2b from mouse serum using protein A-sepharose. Immunochemistry 15:429–436, 1978
Bensinger WI, Baker DA, Buckner DC, Clift RA, Thomas ED: Immunoadsorption for removal of A and B blood group antibodies. N Engl J Med 304:160–162, 1981
Remlinger K, Martin PJ, Hansen JA, Doney KC, Smith A, Deeg HJ, Sullivan K, Storb R, Thomas ED: Treatment of steroid-resistant acute GVHD with murine monoclonal anti-T cell antibodies. Human Immunol, 1983 (in press)
Cosimi AB, Colvin RB, Burton RC, Rubin RH, Goldstein G, Kung PC, Hansen WP, Delmonico FL, Russell PS: Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med 305:308–314, 1981
Hansen JA, Martin PJ, Beatty PG, Clark E, Ledbetter J: Human T lymphocyte cell surface molecules defined by the workshop monoclonal antibodies.In Human Leukocyte Markers by Monoclonal Antibodies, A Bernard, L Boumsell, J. Dausset, C. Milstein, SF Schlossman (eds). New York, Springer-Verlag, 1983 (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martin, P.J., Hansen, J.A. & Thomas, E.D. Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation. J Clin Immunol 4, 18–22 (1984). https://doi.org/10.1007/BF00915282
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00915282